| Company | Value | Change | %Change |
|---|
“..we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2024-25 of ₹110 per Equity Share (Face Value of Rs. 10/- each). The dividend shall be paid on or before March 7, 2025,” Procter & Gamble Hygiene and Health Care said in a regulatory filing.
The company reported an 18% year-on-year (YoY) surge in net profit at ₹364 crore for the second quarter that ended December 31, 2024. In the corresponding quarter of the previous fiscal, Procter & Gamble Hygiene and Health Care posted a net profit of ₹308.5 crore, the company said in a regulatory filing.
Also Read: NALCO Q3 Results | Net profit zooms 3x to ₹1,566 crore, margin doubles; declares dividend
The company’s revenue from operations increased 10.3% to ₹1,247.6 crore as against ₹1,131 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA tanked 39% to ₹371 crore in the third quarter of this fiscal over ₹607.7 crore in the corresponding period in the previous fiscal.EBITDA margin stood at 29.7% in the reporting quarter as compared to 53.7% in the corresponding period in the previous fiscal. EBITDA is earnings before interest, tax, depreciation, and amortisation.
In a challenging operating environment, the company delivered balanced growth in the quarter, with sales of ₹1,248 crore, up 10% versus a year ago driven by a robust portfolio, consumer-delighting innovation and superior retail execution.
Also Read: National Fertilizers Q3 Results | Net profit tanks 70% to ₹46 crore, revenue drops 23%
Kumar Venkatasubramanian, Managing Director, Procter and Gamble Hygiene and Health Care, said, “The company has delivered strong double-digit growth across both top line and bottom line in the quarter.”
Shares of Procter & Gamble Hygiene and Health Care Ltd ended at ₹13,855.20, down by ₹246.50 or 1.75% on the BSE.
First Published: Feb 11, 2025 3:24 PM IS
